Jaw Osteonecrosis Associated with Intravenous Bisphosphonate: Is Incidence Reduced After Adoption of Dental Preventive Measures?

Journal of Oral and Maxillofacial Surgery

Volumn 67, Issue 8, 2009, Pages 1775-

  Fusco, Vittorio ^a   Baraldi, Anna ^a   Loidoris, Anastasios ^a   Ciuffreda, Libero ^a   Galassi, Claudia ^a   Goia, Franco ^a   Scoletta, Matteo ^a   Berrone, Sid ^a   Benech, Arnaldo ^a   Ortega, Cinzia ^a   Berruti, Alfredo ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE;

BONE METASTASIS; BONE NECROSIS; DENTAL CARE; DRUG USE; HUMAN; INCIDENCE; JAW OSTEONECROSIS; LETTER; MULTIPLE MYELOMA; OSTEOPOROSIS; PREVALENCE; PREVENTIVE DENTISTRY; RISK BENEFIT ANALYSIS; SOLID TUMOR;

BONE DENSITY CONSERVATION AGENTS; DENTAL PROPHYLAXIS; DIPHOSPHONATES; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INJECTIONS, INTRAVENOUS; JAW DISEASES; OSTEONECROSIS; PROPORTIONAL HAZARDS MODELS; TIME FACTORS;

EID: 67650177388     PISSN: 02782391     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joms.2009.03.061     Document Type: Letter

References (5)

1. Ripamonti C.I., Maniezzo M., Campa T., et al. Decreased occurrence of osteonecrosis of the jaw after implementation of dental preventive measures in solid tumour patients with bone metastases treated with bisphosphonates: The experience of the National Cancer Institute of Milan. Ann Oncol 20 (2009) 137
2. Dimopoulos M.A., Kastritis E., Bamia C., et al. Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid. Ann Oncol 20 (2009) 117
3. Hoff A.O., Toth B.B., Altundag K., et al. Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates. J Bone Miner Res 23 (2008) 826
4. Fusco V., Vandone A., Vormola R., et al. Osteonecrosis of the jaw (ONJ) in patients (pts) treated with bisphosphonates (BP): A regional experience. Ann Oncol 18 suppl 11 (2007) xi56
5. Aapro M., Abrahamsson P.A., Body J.J., et al. Guidance on the use of bisphosphonates in solid tumours: Recommendations of an international expert panel. Ann Oncol 19 (2008) 420